Resonant Capital Advisors LLC Purchases New Shares in HCA Healthcare, Inc. (NYSE:HCA)

Resonant Capital Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 837 shares of the company's stock, valued at approximately $289,000.

A number of other institutional investors have also modified their holdings of the stock. Atwood & Palmer Inc. acquired a new stake in shares of HCA Healthcare in the 1st quarter worth $28,000. Bartlett & CO. Wealth Management LLC increased its holdings in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after buying an additional 80 shares during the last quarter. ORG Partners LLC increased its position in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after purchasing an additional 86 shares during the last quarter. Tidemark LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth approximately $36,000. Finally, Legacy Investment Solutions LLC boosted its holdings in HCA Healthcare by 99.0% during the 4th quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on HCA. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Finally, Morgan Stanley set a $410.00 target price on HCA Healthcare and gave the company an "equal weight" rating in a research note on Monday, June 9th. Seven investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $395.71.

HCA Healthcare Stock Performance

NYSE HCA opened at $372.84 on Friday. The firm's 50 day simple moving average is $371.55 and its 200 day simple moving average is $339.10. The firm has a market capitalization of $89.69 billion, a price-to-earnings ratio of 16.58, a P/E/G ratio of 1.30 and a beta of 1.47. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The company's quarterly revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the business posted $5.36 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.77%. The ex-dividend date was Monday, June 16th. HCA Healthcare's dividend payout ratio is 12.81%.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.